Background Several rheological disorders of the erythrocytes, such as increased aggregation and decreased deformability, have been observed in diabetes mellitus and have been implicated in the development of diabetic microangiopathy. Structural alterations of the erythrocyte membrane proteins caused by the diabetic process may be at the origin of those observations. In the present study, we searched for erythrocyte membrane protein alterations in diabetic retinopathy. Methods We examined peripheral blood samples from 40 type-2 diabetic patients with diabetic retinopathy of variable severity (19 males and 21 females, mean age 66.8 years, Group A) and we compared them with samples from 19 type-2 diabetic patients without diabetic retinopathy (13 males and six females, mean age 66.5 years, Group B) and 16 healthy volunteers (eight males and eight females, mean age 65.6 years, Group C). Erythrocyte membrane ghosts from all samples were subjected to SDS-PAGE, and the electrophoretic pattern of transmembrane and cytoskeletal proteins was analysed for each sample. The protein quantification of each electrophoretic band was accomplished through scanning densitometry.
Introduction
Diabetic retinopathy constitutes a major social problem, as it is present in nearly 100% of patients who have had type 1 diabetes mellitus for 20 years and in nearly 80% of those with type 2 diabetes of this duration [14] . Furthermore, diabetic retinopathy is the leading cause of blindness in working-age individuals in the industrialised world [33] . Nonproliferative diabetic retinopathy begins with basement membrane thickening and loss of capillary pericytes and endothelial cells [23] , progressively leading to microaneurysms, retinal haemorrhages, venous beading, leakage, and macular oedema. In later stages, capillary closure causes retinal ischemia, which is followed by retinal neovascularization, the hallmark of proliferative diabetic retinopathy, thus increasing the probability of severe visual impairment.
Multiple pathophysiological disorders have been implicated in the development of diabetic microangiopathy, including increased plasma and whole blood viscosity [19] as well as rheological disorders of the erythrocytes, namely increased erythrocyte microviscosity, aggregation, and adhesiveness, and decreased erythrocyte deformability [38] . Rheological disorders of the erythrocytes may be related to specific changes of the mechanical properties of the erythrocyte membrane, potentially associated with structural alterations of membrane lipids or proteins occurring in diabetes of long duration.
The isolation of erythrocyte membrane 'ghosts' free of haemoglobin and cytoplasm [10] enabled the study of the erythrocyte membrane in detail. The erythrocyte membrane is composed of a lipid bilayer, penetrated by the transmembrane proteins, and of the membrane skeleton, formed by the peripheral or cytoskeletal proteins. The membrane skeleton is a bidimensional network that laminates and supports the inner surface of the bilayer. Skeleton proteins are connected to transmembrane ones through anchoring proteins, particularly ankyrin and protein 4.1. The transmembrane proteins include mainly the anion transport protein band 3 and the glycophorins, while the cytoskeletal proteins comprise mainly spectrin and actin [8] .
A number of hereditary haemolytic anaemias, often associated with erythrocyte shape and deformability abnormalities, derive from mutations affecting genes that encode erythrocyte transmembrane, cytoskeletal, or anchoring proteins [8] . If rheological disorders of the erythrocytes indeed participate in the pathogenesis of diabetic microangiopathy, this may well reflect corresponding erythrocyte membrane protein abnormalities. Thus, in the present study we searched for possible structural alterations of the erythrocyte membrane proteins in diabetic retinopathy, as well as for a potential link of such alterations to the severity of retinopathy.
Materials and methods
Three groups of subjects were studied: (1) type-2 diabetic patients with diabetic retinopathy of variable severity (Group A, n=40); (2) type-2 diabetic patients without diabetic retinopathy (Group B, n=19); and (3) healthy nondiabetic age-matched volunteers, who served as controls (Group C, n=16). The main demographic characteristics of those three groups are presented in Table 1 . The study gained approval from the local ethics committee at the University Hospital of Patras, Greece, and informed consent was obtained from all subjects. The investigations were carried out in accordance with the principles of the Declaration of Helsinki. All subjects were offered a thorough eye examination, including visual acuity measurement, slit-lamp examination, tonometry, dilated oph- [9, 12] in the most severely affected eye (Table 2) . After overnight fasting, peripheral venous blood was collected from all subjects into acid citrate EDTA tubes. Serum glucose, cholesterol, and triglycerides, as well as erythrocyte count, haematocrit, haemoglobin, and HbA 1c were measured. The erythrocytes were separated from plasma by centrifugation at 3,000 rpm for 10 min. Membrane ghosts were prepared by hypotonic lysis of erythrocytes in phosphate buffer at 4°C as described by Dodge et al. [10] , with the addition of 0.3 mmol/l phenylmethyl-sulfonyl-fluoride to the lysis buffer to inhibit protease activity. Total protein concentration of each sample was determined using the Bradford protein assay reagent, with bovine serum albumin (Bio-Rad Laboratories, UK) serving as standard. The protein components of each sample were determined by one-dimensional sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions using the discontinuous buffer system of Laemmli [27] and homogeneous or 5-15% linear acrylamide gradient. The gels were stained either with Coomassie blue R-250 for protein staining, or with Periodic Acid-Schiff (PAS) reagent for carbohydrate staining and visualization of glycophorins, as described by Fairbanks et al. [13] .
Individual membrane proteins were identified and quantified, as required, by lengthwise scanning densitometry of either Coomassie blue-or PAS-stained SDS-PAGE gels, using the Gel Analyzer v. 1.0 image-processing program (Biosure, Athens, Greece). The molecular weight (MW) definition of aberrant bands was compared with a lane of MW protein standards. Each sample was analysed in triplicate gels alongside with numerous reference samples (from healthy subjects or patients' control group). The relative amount of each major protein band was expressed as a percentage of total bands measured (namely, spectrin, band 3, 4.1, 4.2, 5, 6, 7, 8, and globin) upon the densitometric scanning of each track. The mean values presented by the studied patient groups (A and B) were compared between them and with those presented by the healthy controls (Group C). Regarding the quantification of the glycophorins, the results were reported as the ratio of each PAS-stained band to the sum of the main bands revealed in each track after double staining of the gel with PAS reagent and (subsequently) Coomassie blue. Protein deficiency/excess was considered significant whenever the mean density of that protein was lower/higher than the mean density minus/plus 2× standard deviation (SD) presented by the reference samples for the same protein.
Hence, any value being out of the described range (i.e. mean density in samples from normal reference people ±2 SDs) was defined as pathological.
Each value was expressed as the mean±SD. The unpaired Student's t-test and the chi-square test were used to compare mean values and frequencies between groups, respectively. In each case, a level of P < 0.05 was considered statistically significant.
Results
The main clinical characteristics of the studied groups are presented in Table 1 . Mean age was similar among the groups, whereas the duration of diabetes was significantly longer in Group A (diabetic retinopathy) than in Group B (diabetes without diabetic retinopathy). Also, as expected, the proportion of insulin-treated patients was significantly higher in Group A compared with Group B.
According to the ETDRS classification (Table 2) , 18 patients (45%) of Group A were diagnosed with nonproliferative diabetic retinopathy, whereas 22 patients (55%) had already developed proliferative diabetic retinopathy (Table 3) . Sixteen patients (40%) of Group A presented high-risk proliferative diabetic retinopathy ( Fig. 1) . The results of laboratory parameters are also shown in Table 1 . Serum glucose and HbA 1c were significantly higher in Groups A and B compared with controls.
Moreover, Group A presented significantly lower haematocrit and haemoglobin compared with the other groups.
Concerning the SDS-PAGE results, there were no significant deviations from normal Coomassie-blue stained electrophoresis of total membrane proteins observed in Groups B (diabetes without diabetic retinopathy) and C (healthy controls), apart from an increase in protein band 8 shown in two samples (11%) from Group B, 120% and 150% above normal values, respectively. In contrast, in 14 samples (35%) from Group A (diabetic retinopathy) we detected deviations concerning increases in protein band 8 (100% to 200% above normal values) and/or membranebound haemoglobin (100% to 340% above normal values) along with a decrease in the major skeletal protein spectrin (20% below normal values). The increase in protein band Fig. 1 Red-free photograph and late-phase fluorescein angiography of the right eye in a 52-year-old male patient with high-risk proliferative diabetic retinopathy according to the ETDRS classification guidelines, as new vessels cover one half of the disc area. Areas of capillary nonperfusion can also be observed in the retinal periphery. Duration of diabetes was 10 years. The patient was under insulin treatment. This patient had abnormal electrophoresis with increased mobility of protein band 3 8 was the most common encountered deviation (70% of the disturbed ghosts), followed by those of membrane-bound haemoglobin and spectrin (40% and 20% of the disturbed ghosts, respectively). In some cases the ghosts were characterized by combined deviations concerning band 8 and haemoglobin (Fig. 2) , or band 8, haemoglobin and spectrin. Furthermore, increased electrophoretic mobility of protein band 3 (Fig. 3) , as well as an aberrant high MW (above 255 kDa) electrophoretic band and a low MW band of 42 kDa (Fig. 4) were evident in ten samples (25%) from patients with diabetic retinopathy (Group A).
The distribution of those Coomassie-blue stained electrophoretic abnormalities upon the degrees of diabetic retinopathy is given in Table 3 . While ten patients with high-risk proliferative diabetic retinopathy (63%) had abnormal electrophoresis (Fig. 1) , no direct correlation of the latter with the severity of retinopathy was evident (Table 3) .
Subsequent staining of the SDS-PAGE gels with the PAS reagent for the detection of membrane glycophorins revealed a deficiency in one or more sialic acid-positive bands in 46% versus 38% of the patients of Groups A and B, respectively. This difference was statistically significant (chi-square test, P<0.001). Notably, in Group-B membrane ghosts the deficiencies predominantly concerned glycophorins B2, A, or C (83% of the aberrations), whereas in Group A the deficiencies predominantly concerned the band of glycophorin A dimers (55% of the aberrations). Furthermore, Group-A membrane ghosts were commonly characterized by generalized reductions in almost all glycophorin bands (20% of the samples). In 12% of both groups, a band with MW close to that of glycophorin A dimers was observed (Fig. 5, upper image) , whereas in some patients with diabetic retinopathy (Group A) more than one aberrant sialoglycoprotein bands appeared with MW of 70 and 55 kDa (Fig. 5, lower image) , probably having arisen from the original glycophorin A and B homoand hetero-dimer bands, respectively.
Females and patients with long duration of diabetes presented more frequent electrophoretic abnormalities. Abnormal electrophoresis was observed in 14/21 females (67%) versus 10/19 males (53%) of Group A (chi-square test, P<0.001). Moreover, duration of diabetes was 21.4± 8.5 years in patients of Group A with abnormal electrophoresis, whereas it was 14.9±8.4 years in patients of Group A with normal electrophoresis (unpaired Student's t-test, P < 0.001). On the other hand, no correlation of abnormal electrophoresis was observed with any of the following parameters: age, insulin treatment, HbA 1c , glucose, cholesterol, triglycerides, erythrocyte count, haematocrit, and haemoglobin.
Discussion
In the present study we demonstrate for the first time the existence of structural alterations of the erythrocyte membrane proteins in diabetic patients that have already developed diabetic retinopathy. Abnormal Coomassie-blue stained electrophoresis of erythrocyte ghost membranes was revealed in more than half of the examined patients with diabetic retinopathy, in all severity grades except mild non-proliferative diabetic retinopathy. In contrast, only 11% of diabetic patients without retinopathy and, as expected, no healthy control subject manifested Coomassie-blue stained electrophoretic abnormalities. In addition, glycophorins were altered in 46% of Group-A patients versus 38% of Group-B patients. Furthermore, long duration of diabetes, which is a more common characteristic in vascular complications of diabetes, seemed to correlate also with abnormal electrophoretic patterns of the erythrocyte membrane proteins. Hyperglycaemia resulting from uncontrolled glucose regulation is widely recognised as a causal link between diabetes and diabetic complications [37] . Chronic hyperglycaemia causes oxidation and non-enzymatic glycosylation (Maillard reaction) of proteins and this applies on the erythrocyte membrane proteins too [31, 45] . Slow turnover of the erythrocyte membrane proteins makes them particularly susceptible to hyperglycaemia [31] . Erythrocyte membrane glycosylation reduces the negative surface electric charge [4, 34] due to cleavage of terminal sialic acid components of glycophorin A, leading to accelerated aging of erythrocytes [28] . It also increases erythrocyte aggregation [36] and accumulates advanced glycation endproducts (AGEs), which have been associated with erythrocyte deformability defects [6] and with microvascular complications of diabetes [7] . Crossline, a special AGE in the erythrocyte membrane is elevated in diabetic retinopathy [47] . In the present study, we were able to show some of the erythrocyte membrane protein alterations that may ensue from altered glucose metabolism to produce diabetic retinopathy.
Erythrocyte membrane proteins serve specific functions. Band 3, for instance, which is the most abundant erythrocyte transmembrane protein and which presented altered mobility in ten samples of Group A in our study, is responsible for anion exchange at the level of plasma membrane [24] . Other transmembrane proteins serve as pumps or channels for the movement of ions and the transport of glucose and other small molecules. In addition, cytoskeletal proteins are important for the maintenance of the biconcave shape and structural integrity of the erythrocyte. Thus, disorders of the erythrocyte membrane proteins may alter the surface electric charge and the mechanical properties of plasma membrane, namely shape and deformability, the latter reflecting the elastic reserve of the erythrocyte when it receives shear stress forces at its passage through small vessels or capillaries. In other words, erythrocyte membrane protein alterations are linked to altered erythrocyte rheology.
There is growing evidence in the literature in favour of the association of haemorrheological abnormalities with diabetes mellitus [5, 11, 19, 30, 38, 48] . Those abnormalities are more and more thought to participate in the pathogenesis of diabetic microangiopathy. In that context, altered rheology of erythrocytes can lead to increased aggregation, endothelial damage, and capillary closure. This particularly applies on diabetic retinopathy, the most common of diabetic vascular microangiopathies [23] . Characteristically, Vekasi et al. [43] found pathological plasma and whole blood viscosity with concomitant increased red blood cell aggregation in patients with diabetic retinopathy compared with controls. Moreover, Goldstein et al. [17] have recently reported differences in the mechanical properties of red blood cells between nonproliferative and proliferative diabetic retinopathy. Our results support those findings by casting light on the pathogenic mechanisms linking erythrocyte membrane protein alterations to subsequent altered erythrocyte rheology and to the development of diabetic retinopathy.
There have been several reports in the literature describing a variety of erythrocyte membrane protein alterations in diabetic humans or animals. Schwartz et al. [38] demonstrated oxidation of spectrin in diabetic erythrocytes. Adewoye et al. [1] reported absent spectrin in insulin-dependent diabetes mellitus, and increased ankyrin and band 6 in both insulin-and non-insulin-dependent diabetes mellitus. Also, Kaymaz et al. [25] showed weaker actin (band 5), absent band 4.5 (related to glycophorins), and absent band 4.9 (dematin) in diabetic cats. However, in those studies most often no data is given about the presence of diabetic microangiopathy. In the present study, we showed that electrophoretic alterations of the erythrocyte membrane proteins were most frequently manifested in the presence of diabetic retinopathy. We therefore believe that the detection of such alterations may help to clarify the pathogenic steps that contribute to the development of diabetic retinopathy, but it may also serve as a blood marker for the existence of diabetic microangiopathy or as a sign of increased risk to develop diabetic microangiopathy.
In agreement to the latter, red blood cell ultrastructure alterations have recently been proposed as a possible progression marker in non-insulin-dependent diabetes mellitus [42] . Interestingly, not only the erythrocytes but also the leukocytes seem to play a role in the pathogenesis and/ or progression of diabetic retinopathy. More specifically, integrins are believed to increase leukocyte adhesion to the retinal endothelium. Elevated levels of integrin CD18 (a transmembrane receptor) on the neutrophils were indicated in a late report as a potential severity marker of diabetic retinopathy in type 2 diabetic patients [41] . Nevertheless, only clinical practice will show whether the above possible severity markers of diabetic retinopathy will assume any utility in the future.
Several possible interpretations to those alterations can be drawn from the literature. Accelerated aging of erythrocytes in diabetes is one of them [28] , consisting of the labelling of erythrocytes with the senescent cell antigen, where an IgG antibody adheres and induces erythrocyte disruption by macrophages [24] . The reported relation of AGEs with macrophages [44] , with chemotactic behaviour to human blood monocytes [26] , and with increased macrophage colony stimulating factor [46] in diabetic microangiopathy supports this mechanism. Interestingly, it has been reported that different chemical insults within the erythrocyte can result in a common 'message' on the outside of the cell, such that the cell appears 'prematurely' aged [21] . Other possible mechanisms include increased susceptibility of the erythrocyte membrane proteins to lysis by endogenous enzymes reported in diabetes [16, 22] , as well as an up-regulation of glucose transporters in the erythrocytes of subjects with chronic hyperglycaemia described by Harik et al. [18] . Increased protein lysis by endogenous enzymes in diabetes is more frequent in females [16] , and this gender predilection was expressed in altered electrophoresis in our results. The above mechanisms may account for altered bands or the emergence of new bands in erythrocyte membrane electrophoresis seen in the present study.
Protein band 8 was increased in 11% of diabetic patients without diabetic retinopathy and in 35% of patients with diabetic retinopathy, while it was the most common encountered electrophoretic deviation in affected ghosts. Band 8 has not been characterized, but it has been shown in combination with increased proportion of membrane-bound haemoglobin in erythrocytes from anaemic patients [3] . Increased amounts of band 8 have also been reported by other groups in the membranes of metabolically stressed red blood cells [32] .
Increased membrane-bound haemoglobin was found only in diabetic retinopathy samples in our study. Previous studies have shown increased proportion of membranebound haemoglobin in a variety of stressed erythrocytes, like in in vivo [35] or in vitro senescent normal erythrocytes, in erythrocytes with defective haemoglobin [2, 3] , and in erythrocytes oxidatively stressed in vitro by various haemolytic agents [29] . In addition, thalassaemic membranes are generally characterized by an increased binding of cytoplasmic proteins like haemoglobin and catalase [2] .
The concomitant decrease in spectrin observed in diabetic retinopathy samples is probably indicative of increased susceptibility of membrane proteins to endogenous proteolysis, previously shown in diabetes mellitus [16, 22] .
Furthermore, increased mobility of band 3 and aberrant electrophoretic bands with MWs of 42 kDa and above 255 kDa were found only in diabetic retinopathy samples in the present study. A similar shift in the apparent molecular mass of band 3 glycoprotein has been detected in all type II congenital dyserythropoietic anaemias (CDA II, HEMPAS) due to underglycosylation of the protein [15] . However, at present we are not able to know whether the increased electrophoretic mobility of band 3 in patients with diabetic retinopathy is attributed to a glycosylation defect or to increased proteolysis.
As for the aberrant low MW bands, they probably arise from increased proteolysis of original membrane proteins. The high MW band of above 255 kDa has previously been found in membranes of oxidatively stressed erythrocytes as a crosslinkage event between spectrin and haemoglobin.
The formation of spectrin-haemoglobin crosslinking represents a well-known oxidant damage of the senescent erythrocyte membrane [40] . Its reproduction in vitro by hydrogen peroxide treatment is associated with echinocyte transformation, membrane rigidity, adherence and phagocytosis [39] .
Finally, regarding PAS staining results of the present study, a deficiency in PAS-positive bands was significantly more frequent in diabetic retinopathy (Group A) samples (46%) compared with that of Group B samples (38%). This may constitute evidence of more advanced glycosylation of the erythrocyte membrane proteins in diabetic retinopathy. Of interest, there was a different specificity regarding the sialoglycoproteins affected in Group A and B samples, with the deficiency of glycophorin A dimers and total glycophorin bands being dominant in Group A samples. Future research may reveal the biochemical basis of this distinction and, possibly, its clinical importance.
From a clinical point of view, the results of our study raise also the issue of a possible preventive or therapeutic intervention to erythrocyte rheology in diabetic retinopathy. The reported increased erythrocyte deformability in type 2 diabetic patients with retinopathy by Ginkgo biloba extract 761 [20] is an example of that trend, yet more literature data are required. As AGEs are irreversibly attached to macromolecules and their levels do not decline when glucose levels are corrected, inhibition of AGE formation could be combined with agents that enhance erythrocyte flexibility and improve blood rheology. Prevention of diabetic retinopathy could therefore be directed onto the inhibition of erythrocyte membrane protein glycosylation, the enhancement of erythrocyte deformability, and the reduction of erythrocyte aggregation.
In conclusion, structural alterations of the erythrocyte membrane proteins, which probably derive from oxidation and nonenzymatic glycosylation of those proteins in chronic diabetes and which can affect the erythrocyte rheology, may be associated with the development of microvascular complications of diabetes, in particular diabetic retinopathy. A lot of such protein alterations are shown exclusively in association with diabetic retinopathy in the present study. Their detection may serve as a blood marker for the development of diabetic microangiopathy or as a sign of increased risk to develop diabetic microangiopathy. Further studies are needed to assess whether pharmaceutical intervention to the rheology of erythrocytes can prevent or alleviate microvascular diabetic complications.
